Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Pleomorphic Xanthoastrocytoma with Anaplastic Features: Retrospective Case Series.

Rutkowski MJ, Oh T, Niflioglu GG, Safaee M, Tihan T, Parsa AT.

World Neurosurg. 2016 Nov;95:368-374. doi: 10.1016/j.wneu.2016.07.068. Epub 2016 Jul 28.

PMID:
27476694
2.

Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Perkins SM, Mitra N, Fei W, Shinohara ET.

J Neurooncol. 2012 Oct;110(1):99-104. doi: 10.1007/s11060-012-0939-8. Epub 2012 Jul 28.

PMID:
22843450
3.

BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.

Ma C, Feng R, Chen H, Hameed NUF, Aibaidula A, Song Y, Wu J.

World Neurosurg. 2018 Dec;120:e1225-e1233. doi: 10.1016/j.wneu.2018.09.050. Epub 2018 Sep 18.

PMID:
30240866
4.

Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.

Ida CM, Rodriguez FJ, Burger PC, Caron AA, Jenkins SM, Spears GM, Aranguren DL, Lachance DH, Giannini C.

Brain Pathol. 2015 Sep;25(5):575-86. doi: 10.1111/bpa.12217. Epub 2014 Dec 5.

5.

Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

Schmidt Y, Kleinschmidt-DeMasters BK, Aisner DL, Lillehei KO, Damek D.

J Neurooncol. 2013 Jan;111(1):59-69. doi: 10.1007/s11060-012-0991-4. Epub 2012 Oct 25.

6.

BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.

Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D.

Eur J Surg Oncol. 2015 Dec;41(12):1685-90. doi: 10.1016/j.ejso.2015.09.012. Epub 2015 Sep 30.

PMID:
26454767
7.

Pleomorphic xanthoastrocytoma: what do we really know about it?

Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP.

Cancer. 1999 May 1;85(9):2033-45.

PMID:
10223246
8.

Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.

Marton E, Feletti A, Orvieto E, Longatti P.

J Neurol Sci. 2007 Jan 31;252(2):144-53. Epub 2006 Dec 26. Review.

PMID:
17189643
9.

Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.

Montano N, Papacci F, Cioni B, Gaudino S, Della Pepa GM, Conforti G, Di Bonaventura R, Novello M, Lauriola L, Meglio M.

J Clin Neurosci. 2013 Nov;20(11):1605-8. doi: 10.1016/j.jocn.2012.09.046. Epub 2013 Jul 1.

PMID:
23827171
10.

Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.

Pahapill PA, Ramsay DA, Del Maestro RF.

Neurosurgery. 1996 Apr;38(4):822-8; discussion 828-9. Review.

PMID:
8692406
11.

Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients.

Yu S, He L, Zhuang X, Luo B.

Acta Radiol. 2011 Mar 1;52(2):223-8. doi: 10.1258/ar.2010.100221.

PMID:
21498352
12.

Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.

Gallo P, Cecchi PC, Locatelli F, Rizzo P, Ghimenton C, Gerosa M, Pinna G.

Br J Neurosurg. 2013 Dec;27(6):759-64. doi: 10.3109/02688697.2013.776666. Epub 2013 Mar 20.

PMID:
23514331
13.

Pleomorphic xanthoastrocytomas: institutional experience of 18 patients.

Oh T, Kaur G, Madden M, Bloch O, Parsa AT.

J Clin Neurosci. 2014 Oct;21(10):1767-72. doi: 10.1016/j.jocn.2014.04.002. Epub 2014 Jun 17.

PMID:
24950906
14.

A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.

Asano K, Miyamoto S, Kubo O, Kikkukawa T, Yagihashi A, Ohkuma H.

Brain Tumor Pathol. 2006 Apr;23(1):55-63.

PMID:
18095120
15.

Pediatric Pleomorphic Xanthoastrocytoma Treated With Surgical Resection Alone: Clinicopathologic Features.

Dodgshun AJ, Sexton-Oates A, Saffery R, MacGregor D, Sullivan MJ.

J Pediatr Hematol Oncol. 2016 Oct;38(7):e202-6. doi: 10.1097/MPH.0000000000000581.

PMID:
27123665
16.

[Clinicopathologic study of pleomorphic xanthoastrocytoma of brain].

Li NY, Zhou J, Zhou HB, Ma HH.

Zhonghua Bing Li Xue Za Zhi. 2006 Aug;35(8):453-7. Chinese.

PMID:
17069696
17.

Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.

Tonse R, Gupta T, Epari S, Shastri JG, Gurav M, Bano N, Jalali R.

J Neurooncol. 2018 Jan;136(2):343-350. doi: 10.1007/s11060-017-2658-7. Epub 2017 Nov 16.

PMID:
29147864
18.

Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.

Furuta T, Miyoshi H, Komaki S, Arakawa F, Morioka M, Ohshima K, Nakada M, Sugita Y.

Neuropathology. 2018 Jun;38(3):218-227. doi: 10.1111/neup.12459. Epub 2018 Mar 13.

PMID:
29532523
19.

Pleomorphic xanthoastrocytoma in children and adolescents.

Rao AA, Laack NN, Giannini C, Wetmore C.

Pediatr Blood Cancer. 2010 Aug;55(2):290-4. doi: 10.1002/pbc.22490.

PMID:
20582976
20.

Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation.

Koga T, Morita A, Maruyama K, Tanaka M, Ino Y, Shibahara J, Louis DN, Reifenberger G, Itami J, Hara R, Saito N, Todo T.

Neuro Oncol. 2009 Aug;11(4):446-51. doi: 10.1215/15228517-2008-112. Epub 2009 Jan 22.

Supplemental Content

Support Center